Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with ...

Metabolics Pharma Announces Positive Top-Line Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects ...

Editorial: The health department rolling out jabs to patients who struggle with their weight must be a moment to rethink our approach to childhood obesity, so often the precursor to a lifetime of poor ...

For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and that this effect is independent of weight loss,” the researchers concluded ...

A large study led by researchers at Case Western Reserve University suggests that semaglutide—a drug already popular for ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...

Wegovy, a weight-loss injection containing semaglutide, has arrived in India, offering a new approach to combatting obesity ...